CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CSPC Pharmaceutical Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CSPC Pharmaceutical Group Ltd
No. 226 Huanghe Avenue
Phone: +86 31187037015p:+86 31187037015 SHIJIAZHUANG, HEB  050035  China Ticker: 10931093

Business Summary
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board DongchenCai 69 5/27/2022 1/1/1998
Executive Vice Chairman of the Board, Chief Executive Officer CuilongZhang 54 5/27/2022 7/9/2018
Executive Director Kin ManChak 57 12/1/2005 12/1/2005
12 additional Officers and Directors records available in full report.

Business Names
Business Name
1093
China Pharmaceutical Enterprise & Inv.
China Pharmaceutical Group Limited
CHJTF
CHPTY
CSPC shengxue glucose co., ltd.

General Information
Number of Employees: 23,500 (As of 12/31/2023)
Outstanding Shares: 11,903,219,732 (As of 12/31/2023)
Shareholders: 8,700
Stock Exchange: HKG
Fax Number: +86 31187039608


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024